Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
3,838,602,439
-
Total 13F shares
-
131,231
-
Share change
-
+19,404
-
Total reported value
-
$193,878
-
Price per share
-
$1.48
-
Number of holders
-
13
-
Value change
-
+$24,967
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) as of Q1 2025
As of 31 Mar 2025 Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 131,231 shares of stock of the company.
Largest 10 holders included RHUMBLINE ADVISERS, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, XTX Topco Ltd, Virtu Financial LLC, CAPTRUST FINANCIAL ADVISORS, FIFTH THIRD BANCORP, WELLS FARGO & COMPANY/MN, Costello Asset Management, INC, and NATIONAL BANK OF CANADA /FI/.
This table shows 13 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.